Carregant...
Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks
Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignancy. Existing therapeutic strategies only provide a small survival benefit in patients with PDAC. Laboratory and clinical research have identified various populations of stem-cell-like cancer cells or cancer stem c...
Guardat en:
| Publicat a: | J Clin Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6571629/ https://ncbi.nlm.nih.gov/pubmed/31108941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8050702 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|